Cargando…

Novel anti-malarial drug strategies to prevent artemisinin partner drug resistance: A model-based analysis

Emergence of resistance to artemisinin and partner drugs in the Greater Mekong Subregion has made elimination of malaria from this region a global priority; it also complicates its achievement. Novel drug strategies such as triple artemisinin combination therapies (ACTs) and chemoprophylaxis have be...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kunkel, Amber, White, Michael, Piola, Patrice
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8023453/ https://www.ncbi.nlm.nih.gov/pubmed/33764971 http://dx.doi.org/10.1371/journal.pcbi.1008850

Ejemplares similares

Artemisinin anti-malarial drugs in China
por: Guo, Zongru
Publicado: (2016)

Editorial to the Feature article “Artemisinin anti-malarial drugs in China”
por: Zhang, Ao
Publicado: (2016)

Anti-malarial drug, artemisinin and its derivatives for the treatment of respiratory diseases
por: Cheong, Dorothy H.J., et al.
Publicado: (2020)

Profiling of the anti-malarial drug candidate SC83288 against artemisinins in Plasmodium falciparum
por: Duffey, Maëlle, et al.
Publicado: (2018)

Anti-malarial drug: the emerging role of artemisinin and its derivatives in liver disease treatment
por: Xiong, Ye, et al.
Publicado: (2021)

Biotechnological Approaches for Production of Artemisinin, an Anti-Malarial Drug from Artemisia annua L.
por: Al-Khayri, Jameel M., et al.
Publicado: (2022)

Acquired resistance of malarial parasites against artemisinin-based drugs: social and economic impacts
por: Porter-Kelley, Johanna M, et al.
Publicado: (2010)

Synergistic anti-malarial action of cryptolepine and artemisinins
por: Forkuo, Arnold D., et al.
Publicado: (2016)

Anticancer Effect of AntiMalarial Artemisinin Compounds
por: Das, AK
Publicado: (2015)

In vitro activity of anti-malarial ozonides against an artemisinin-resistant isolate
por: Baumgärtner, Fabian, et al.
Publicado: (2017)

Spread of anti-malarial drug resistance: Mathematical model with implications for ACT drug policies
por: Pongtavornpinyo, Wirichada, et al.
Publicado: (2008)

Resistance to Artemisinin Combination Therapies (ACTs): Do Not Forget the Partner Drug!
por: Nsanzabana, Christian
Publicado: (2019)

Partner-Drug Resistance and Population Substructuring of Artemisinin-Resistant Plasmodium falciparum in Cambodia
por: Parobek, Christian M., et al.
Publicado: (2017)

Triple artemisinin-containing combination anti-malarial treatments should be implemented now to delay the emergence of resistance
por: White, Nicholas J.
Publicado: (2019)

Erratum to: Synergistic anti-malarial action of cryptolepine and artemisinins
por: Forkuo, Arnold D., et al.
Publicado: (2016)

Pre-existing partner-drug resistance to artemisinin combination therapies facilitates the emergence and spread of artemisinin resistance: a consensus modelling study
por: Watson, Oliver J, et al.
Publicado: (2022)

The impact of anti-malarial markets on artemisinin resistance: perspectives from Burkina Faso
por: Guissou, Rosemonde M., et al.
Publicado: (2023)

In vitro and in vivo anti-malarial activity of novel harmine-analog heat shock protein 90 inhibitors: a possible partner for artemisinin
por: Bayih, Abebe Genetu, et al.
Publicado: (2016)

Assessing the potential impact of artemisinin and partner drug resistance in sub-Saharan Africa
por: Slater, Hannah C., et al.
Publicado: (2016)

The role of anti-malarial drugs in eliminating malaria
por: White, Nicholas J
Publicado: (2008)

Prospective strategies to delay the evolution of anti-malarial drug resistance: weighing the uncertainty
por: Smith, David L, et al.
Publicado: (2010)

Anti-malarial prescribing practices in Sudan eight years after introduction of artemisinin-based combination therapies and implications for development of drug resistance
por: Elmannan, Abeer Abuzeid Atta, et al.
Publicado: (2015)

Hyperparasitaemia and low dosing are an important source of anti-malarial drug resistance
por: White, Nicholas J, et al.
Publicado: (2009)

Preventing antimalarial drug resistance with triple artemisinin-based combination therapies
por: Nguyen, Tran Dang, et al.
Publicado: (2023)

Assessment of global reporting of adverse drug reactions for anti-malarials, including artemisinin-based combination therapy, to the WHO Programme for International Drug Monitoring
por: Kuemmerle, Andrea, et al.
Publicado: (2011)

Drug resistance genomics of the antimalarial drug artemisinin
por: Winzeler, Elizabeth A, et al.
Publicado: (2014)

More than anti-malarial agents: therapeutic potential of artemisinins in neurodegeneration
por: Lu, Bing-Wen, et al.
Publicado: (2019)

Cellular engineering of Artemisia annua and Artemisia dubia with the rol ABC genes for enhanced production of potent anti-malarial drug artemisinin
por: Kiani, Bushra Hafeez, et al.
Publicado: (2016)

The power of pooled analysis to inform optimal dosing strategies for Artemisinin Combination Therapies (ACTs)
por: Guerin, Philippe J, et al.
Publicado: (2012)

Anti‐malarial drug effects on parasite dynamics in vivax malaria
por: White, Nicholas J.
Publicado: (2021)

Anti-malarial plants in Ethiopia and their activities on drug-resistant malaria
por: Sema, Yimeslal Atnafu, et al.
Publicado: (2022)

Computational screening of molecular targets in Plasmodium for novel non resistant anti-malarial drugs
por: Singh, Neera, et al.
Publicado: (2009)

CRIMALDDI: platform technologies and novel anti-malarial drug targets
por: Vial, Henri, et al.
Publicado: (2013)

The effect of intermittent preventive treatment on anti-malarial drug resistance spread in areas with population movement
por: Teboh-Ewungkem, Miranda I, et al.
Publicado: (2014)

Anti-malarial drugs and the prevention of malaria in the population of malaria endemic areas
por: Greenwood, Brian
Publicado: (2010)

Modulating effects of plasma containing anti-malarial antibodies on in vitro anti-malarial drug susceptibility in Plasmodium falciparum
por: Monatrakul, Preeyaporn, et al.
Publicado: (2010)

Saleability of anti-malarials in private drug shops in Muheza, Tanzania: a baseline study in an era of assumed artemisinin combination therapy (ACT)
por: Ringsted, Frank M, et al.
Publicado: (2011)

Analysis of anti-malarial resistance markers in pfmdr1 and pfcrt across Southeast Asia in the Tracking Resistance to Artemisinin Collaboration
por: Srimuang, Krongkan, et al.
Publicado: (2016)

Tools for surveillance of anti-malarial drug resistance: an assessment of the current landscape
por: Nsanzabana, Christian, et al.
Publicado: (2018)

Substandard anti-malarial drugs in Burkina Faso
por: Tipke, Maike, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_6tpjsgjkbcd3sd3na6qdt7dgiq